KIT to help Korean drugs gain U.S. FDA approval

Published: 2013-03-12 06:57:00

Updated: 2013-03-12 06:57:00

The Korea Institute of Toxicology (KIT), a world-class non-clinical contract research organization (CRO) located in Daejeon, is planning to support pharmaceutical companies’ advancement into the U.S. market as the organization received the "voluntary action indicated (VAI) from the U.S. Food and ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK